CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)	3 Months Ended		6 Months Ended
	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)
Cash flows from operating activities:
Net (loss) income	$ 35,643,000	$ 6,060,000	$ 47,187,000	$ 2,329,000
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization			8,616,000	2,953,000
Amortization of deferred financing costs			132,000	153,000
Amortization of debt fair value adjustment			(166,000)	0
Amortization of restricted stock and restricted stock units			1,975,000	1,107,000
Equity in (earnings) loss of unconsolidated joint ventures	50,000	492,000	(1,180,000)	1,837,000
Equity in earnings of sale of real estate of unconsolidated venture	(40,098,000)	0	(53,059,000)	0
Impairment charge	0	520,000	0	520,000
Gain on sale of real estate	0	(7,279,000)	(6,000)	(7,279,000)
Gain on sale of partnership interest	0	(2,244,000)	0	(2,244,000)
Loss on extinguishment of debt	563,000	0	563,000	0
Increases and decreases from changes in other assets and liabilities:
Increase in other assets			(432,000)	(443,000)
Decrease in accounts payable and accrued liabilities			(851,000)	(2,021,000)
Net cash provided by (used in) operating activities			2,779,000	(3,088,000)
Cash flows from investing activities:
Improvements to real estate properties			(1,807,000)	(594,000)
Purchase of investment in joint ventures			(42,784,000)	0
Proceeds from the sale of real estate			4,385,000	24,133,000
Proceeds from the sale of partnership interest			0	7,540,000
Distributions from unconsolidated joint ventures			74,670,000	8,053,000
Contributions to unconsolidated joint ventures			(3,044,000)	(6,031,000)
Net cash provided by investing activities			31,420,000	33,101,000
Cash flows from financing activities:
Proceeds from mortgages payable			18,953,000	0
Mortgage payoffs			(26,761,000)	(14,260,000)
Mortgage principal payments			(821,000)	(1,559,000)
Increase in deferred financing costs			(264,000)	(38,000)
Dividends paid			(8,460,000)	(7,592,000)
Distributions to non-controlling interests			(60,000)	0
Proceeds from the sale of common stock			6,125,000	7,349,000
Net cash used in financing activities			(11,288,000)	(16,100,000)
Net increase in cash, cash equivalents and restricted cash:			22,911,000	13,913,000
Cash, cash equivalents and restricted cash at beginning of period			38,921,000	28,685,000
Cash, cash equivalents and restricted cash at end of period	61,832,000	42,598,000	61,832,000	42,598,000
Supplemental disclosure of cash flow information:
Cash paid during the period for interest			4,826,000	3,118,000
Cash paid for income taxes			291,000	194,000
Consolidation on buyout of partnership interests:
Increase in real estate assets			(159,121,000)
Increase in other assets			(6,972,000)
Increase in mortgage payable			107,757,000
Increase in deferred loan costs			(2,272,000)
Increase in accounts payable and accrued liabilities			2,646,000
Decrease in investment in unconsolidated joint ventures			15,178,000
Purchase and consolidation of investment in joint venture			(42,784,000)	0
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows.
Cash and cash equivalents	57,045,000	34,666,000	57,045,000	34,666,000
Restricted cash	4,787,000	7,932,000	4,787,000	7,932,000
Total cash, cash equivalents and restricted cash, shown in consolidated statement of cash flows	$ 61,832,000	$ 42,598,000	$ 61,832,000	$ 42,598,000